ZBIO vs CELC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

ZBIO

46.4
AI Score
VS
ZBIO Wins

CELC

37.7
AI Score

Investment Advisor Scores

ZBIO

46score
Recommendation
HOLD

CELC

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric ZBIO CELC Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -100.0% 0.0% CELC
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 46.4/100 37.7/100 ZBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL ZBIO

Relative Price Performance (Last 90 Days)

ZBIO 1M: -0.5% · 3M: +75.2% CELC 1M: -9.4% · 3M: -6.7%

Current Technical Phase

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.3 · Price: $31.12

CELC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.3%), weak momentum, RSI 38

RSI (14): 38.1 · Price: $83.45

Fundamentals Snapshot

Metric ZBIO CELC
Market Cap
Forward P/E -6.7 -1043.1
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.0%
Gross Margin -212.5%
Operating Margin -77.7% 0.0%
EPS -9.27 -4.30
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.